ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary Bladder Cancer

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...
The Malaysian Reserve

Brenig Therapeutics Announces Initiation of First-in-Human Study of BT-409, a Brain-Selective NLRP3 Inhibitor, and Provides Update on BT-267, its LRRK2 Program

Brenig Therapeutics, Inc. (Brenig), a clinical-stage biotechnology company advancing small-molecule therapies for ...

BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without ...

Clinical Study Evaluating a Long-Acting Naltrexone Implant Under the FDA's 505(b)(2) Pathway ANAHEIM, CA - January 14, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer ...
The New York Times

The New AirPods Can Translate Languages in Your Ears. This Is Profound.

The technology is one of the strongest examples yet of how artificial intelligence can be used in a seamless, practical way to improve people’s lives. By Brian X. Chen Brian X. Chen is The Times’s ...
Frontiers

Eukaryotic initiation factors: central factor associating mRNA translational plasticity during neuropathic pain progression

Neuropathic pain causes plasticity in the nervous system, which is often associated with altered protein synthesis. Proteins are the key executors of cellular functions, and their alteration is ...
Catholic News Agency

Becoming Catholic: Everything you need to know about OCIA

The recent election of Pope Leo XIV has sparked new interest in Catholicism, with Google data showing a spike in searches on “how to become Catholic” shortly after the death of Pope Francis in April.
Carnegie Institution for Science

GIGYF2 and 4EHP Inhibit Translation Initiation of Defective Messenger RnAs to Assist Ribosome-Associated Quality control

Ribosome-associated Quality Control (RQC) pathways protect cells from toxicity caused by incomplete protein products resulting from translation of damaged or problematic mRnAs. Extensive work in yeast ...